Otonomyincwas A Biopharmaceutical Company Based In San Diegocaliforniadedicated To Developing Therapeutics For Neurotological Conditionsparticularly Those Affecting The Earfounded In 2008The Company Focused On Sustained Exposure Drug Formulations To Address Unmet Needs In Otologytargeting Conditions Such As Tinnitushearing Lossand Balance Disorders Otonomy S Product Lineup Included Otiprioa An Otic Suspension For Preventing Infections During Pediatric Tympanostomy Tube Placementand Several Candidates In Various Stages Of Developmentthese Included Oto 313 For Tinnitusoto 413 For Cochlear Synaptopathy Repairoto 510 As An Otoprotectantoto 825 For Congenital Hearing Lossand Oto 6Xx For Hair Cell Regenerationthe Company Also Engaged In Collaborations With Institutions Like The University Of California And Durect Corporation For Gene Therapy Advancementsotonomy Ceased Operations On March 282023
No conferences found for this company.
| Company Name | Otonomy Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
